ARTICLE | Clinical News
Piqur preclinical data
September 2, 2013 7:00 AM UTC
Piqur said PQR-309 led to anti-proliferative activity in vitro and antitumor efficacy in vivo, but could not be reached for details. The company plans to start Phase I testing of the dual inhibitor of...